Global Coordination of Antimicrobial
Resistance Research

The Joint Programming Initiative on Antimicrobial Resistance, JPIAMR, is a global collaborative organisation and platform, engaging 29 nations to curb antimicrobial resistance (AMR) with a One Health approach.

29

countries

156

projects & networks

141

M€ invested

Strategic Research & Innovation Agenda

The JPIAMR Strategic Research and Innovation Agenda on Antimicrobial Resistance (SRIA) presents an overview of recent developments and future needs for AMR research.

AMR Knowledge Hub

JPIAMR provides here access to a collection of resources on AMR research networks, research performing institutes or centres and infrastructures.

One Health AMR

The candidate European Partnership on One Health Antimicrobial Resistance (OH AMR) is prepared by the Coordination and Support Action DESIGN OH AMR in collaboration with JPIAMR and other stakeholders.

Latest events

Webinar for applicants in the call “AMR Diagnostics and Surveillance 2023”

Jan 24, 2023 12:00 - Jan 24, 2023 (CET)

JPIAMR is pleased to invite researchers to a live webinar presenting the 2023 call on AMR diagnostics and surveillance, “Development of innovative strategies, tools, technologies and methods for diagnostics and surveillance of antimicrobial resistance”, and the partner search tool.

Social sciences in AMR research and innovation

Jan 10, 2023 10:00 - Jan 10, 2023 (CET)

AMR can only be tackled in a multidisciplinary manner, and there is a clear need to integrate the full spectrum of social science and humanities disciplines, including economics, political science, ethics, sociology, anthropology, psychology, and law.

This webinar will provide an overview of the OH AMR partnership and how social sciences and humanities are integrated with the research and innovation objectives. We will also share examples of how social sciences have contributed to projects funded previously by JPIAMR.

Tackling the emerging threat of fungal drug resistance

Jun 23, 2022 14:00 - Jun 23, 2022 (CEST)

Invasive fungal infections pose a threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide. This live webinar will discuss the emerging threat of fungal drug resistance and identify opportunities and priorities in fungal resistance research.

Developing Diagnostic tools for Drug Resistant Infections for Human and Animal Health

Jun 22, 2022 13:30 - Jun 22, 2022 (CEST)

In this workshop we will explore the main barriers to industry in developing diagnostic tools for drug-resistant infections for human and animal health and how JPIAMR and other stakeholders (industry, academia, funders, and regulatory agencies, among others) can work together to improve the translation of these developments.

View all events

Latest news

Yellow wall and flowers

JPIAMR at ECCMID 2023

Mar 9, 2023

JPIAMR is co-organising the session “Developing your funding application: from drug discovery to drug development” at the ECCMID 2023 conference.

JPIAMR Activity Report 2022

Feb 3, 2023

The JPIAMR activity report now published summarises the achievements of JPIAMR and the major events conducted in the year 2022.

Research call on AMR Diagnostics and surveillance now open

Jan 16, 2023

The call “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance” is now open. 

This call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance. It involves 22 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

Online Consultation: Research and Innovation Objectives for the OH AMR Partnership

Dec 5, 2022

The candidate One Health Antimicrobial Resistance partnership (OH AMR) has been identified by the European Commission as one of the candidate European Partnerships of Horizon Europe. Currently, the Research and Innovation Objectives of OH AMR are under preparation, and we now invite researchers, stakeholders, scientists, policymakers, clinicians, patient groups, AMR-related organisations, and others to provide feedback on the elements included in the Research and Innovations Objectives.

View all news